Skip to content

Why single-cell technologies are vital for Endometriosis research webinar

Why single-cell technologies are vital for Endometriosis research


Learn why single-cell technologies are vital for Endometriosis research by watching our webinar

Endometriosis is a debilitating disease that affects 10% of women and girls of reproductive age. There is no cure, no certain cause and no non-invasive method of diagnosing the disease, leading to a reduced quality of life for the patients and a significant socio-economic burden. Join us on our webinar on why single-cell technologies are vital for endometriosis research.

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of this disease requires a novel research approach by single-cell analysis. Therefore, Prof. Dr. med. Müller started collaborating with Scailyte AG, the specialist in single-cell analysis. In a joint project, they strive to develop a non-invasive diagnosis method, and potentially a prognostic method to reduce the suffering of endometriosis patients. Prof. Mueller is a renowned gynaecologist and gynaecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). He is the founding member and current president of the working group for Endoscopic Gynecology.

Join this webinar with Prof. Mueller, in cooperation with Scailyte, to learn more about “Why single-cell technologies are vital for Endometriosis research.”

Watch the webinar here: https://youtu.be/XPmhGRy-1AY

 

 

About Scailyte

Scailyte AG is a data-driven biomarker discovery company, founded in Luzern, Switzerland in 2017. The ETH Spin-off is using cutting edge technologies within the single-cell space and a proprietary biomarker discovery platform to develop clinical diagnostic applications in oncology and women’s health. Scailyte is ranked among the Top100 Swiss Startups since 2019 and has won the MassChallenge Switzerland in 2018. www.scailyte.com
ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Recent News

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Recent News

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

Recent News

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News

01 /04

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

02 /04

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

03 /04

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

04 /04

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News